alosetron vs pantoprazole
PlainMeds reviewed this comparison against our methodology in August 2026. It places FDA and CMS record fields side by side, without recommending either medication.
Side-by-side comparison of alosetron and pantoprazole. Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Lotronex
Protonix
Alosetron (Lotronex) is a medicine for women with severe diarrhea-predominant irritable bowel syndrome (IBS). It helps to reduce diarrhea and stomach pain.
Pantoprazole is a drug that reduces stomach acid. It belongs to a class of drugs called proton pump inhibitors (PPIs).
Alosetron is used to treat severe diarrhea-predominant irritable bowel syndrome (IBS) in women. It is for women whose IBS symptoms have lasted for 6 months or longer. You should have already ruled out other possible causes of your symptoms. This medicine is only for you if other treatments have not worked well enough.
This medicine treats gastroesophageal reflux disease (GERD) and erosive esophagitis (EE) in adults, for up to 10 days. GERD is when stomach acid flows back into your esophagus, causing heartburn. It also treats conditions where your stomach makes too much acid, like Zollinger-Ellison (ZE) Syndrome.
Alosetron blocks a substance called serotonin in your gut. Serotonin can speed up bowel movements. By blocking serotonin, alosetron slows down your bowel and reduces diarrhea.
Pantoprazole works by blocking the enzyme in the stomach that produces acid. This reduces the amount of acid your stomach makes. It helps to heal damage to the esophagus caused by acid reflux.
- • Constipation
- • Abdominal discomfort and pain
- • Nausea
- • Gastrointestinal discomfort and pain
- • Headache
- • Diarrhea
- • Nausea
- • Abdominal pain
- • Vomiting
- Diarrhoea 10
- Nausea 8
- Abdominal Pain 6
- Death 6
- Constipation 5
- Fatigue 19,879
- Nausea 16,988
- Diarrhoea 16,633
- Dyspnoea 16,592
- Pain 14,962
Alosetron can cause serious gut problems, like ischemic colitis (reduced blood flow to the bowel) and severe constipation. These problems can lead to hospitalization, surgery, or even death. Stop taking alosetron right away if you get constipated or have symptoms of ischemic colitis, like bloody diarrhea or bad stomach pain. Call your doctor immediately.
Pantoprazole can hide the symptoms of stomach cancer, so tell your doctor if your symptoms don't improve. It may also increase your risk of diarrhea caused by a bacteria called *C. difficile*. Long-term use may increase your risk of bone fractures. This medicine may also cause kidney problems, lupus, low magnesium levels, and polyps in the stomach.
It is not known if alosetron can harm your unborn baby. Talk to your doctor if you are pregnant or plan to become pregnant. It is also not known if alosetron passes into breast milk. Talk to your doctor about the best way to feed your baby if you take alosetron.
Based on animal studies, this medicine may harm your unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.
Also Compare, Nearby Drugs
Compare pantoprazole with
How to Read This alosetron vs pantoprazole Comparison
alosetron is classified in the 5-HT3 Antagonist (IBS-D) drug class, while pantoprazole sits within the Proton Pump Inhibitor (PPI) class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are prescription-only, so a licensed provider must authorize use.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, alosetron has 35 submissions while pantoprazole has 85,054. Those figures reflect cumulative reporting volume, not per-patient risk, so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot represent individual circumstances. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This registry does not provide medical, treatment, substitution, or medication-change directions for alosetron or pantoprazole.
Registry boundary: This comparison displays source-record fields and does not provide individualized medical direction.